Strong Wall Street Debut Shows Potential Of Indian Billionaire-Backed Bicara’s Cancer Drugs

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% from its IPO price in its first week of trading on Nasdaq as investors on Wall Street gave the cancer drug developer a strong vote of confidence.